Journal Article
. 2020 Oct;10(1).
doi: 10.1038/s41598-020-73700-1.

Transcriptome-wide analysis and modelling of prognostic alternative splicing signatures in invasive breast cancer: a prospective clinical study

Linbang Wang 1 Yuanyuan Wang 1 Bao Su 2 Ping Yu 1 Junfeng He 1 Lei Meng 1 Qi Xiao 1 Jinhui Sun 1 Kai Zhou 2 Yuzhou Xue 2 Jinxiang Tan 3 
  • PMID: 33020551
  •     59 References


Aberrant alternative splicing (AS) has been highly involved in the tumorigenesis and progression of most cancers. The potential role of AS in invasive breast cancer (IBC) remains largely unknown. In this study, RNA sequencing of IBC samples from The Cancer Genome Atlas was acquired. AS events were screened by conducting univariate and multivariate Cox analysis and least absolute shrinkage and selection operator regression. In total, 2146 survival-related AS events were identified from 1551 parental genes, of which 93 were related to prognosis, and a prognostic marker model containing 14 AS events was constructed. We also constructed the regulatory network of splicing factors (SFs) and AS events, and identified DDX39B as the node SF gene, and verified the accuracy of the network through experiments. Next, we performed quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) in triple negative breast cancer patients with different responses to neoadjuvant chemotherapy, and found that the exon-specific expression of EPHX2, C6orf141, and HERC4 was associated with the different status of patients that received neoadjuvant chemotherapy. In conclusion, this study found that DDX39B, EPHX2 (exo7), and HERC4 (exo23) can be used as potential targets for the treatment of breast cancer, which provides a new idea for the treatment of breast cancer.

Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.
Andriy Marusyk, Doris P Tabassum, +3 authors, Kornelia Polyak.
Nature, 2014 Aug 01; 514(7520). PMID: 25079331    Free PMC article.
Highly Cited.
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
A Sveen, S Kilpinen, +2 authors, R I Skotheim.
Oncogene, 2015 Aug 25; 35(19). PMID: 26300000
Highly Cited. Review.
Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma.
Chengkun Yang, Qiongyuan Wu, +10 authors, Tao Peng.
Front Oncol, 2019 Jul 06; 9. PMID: 31275849    Free PMC article.
Epidermal growth factor stimulates proliferation and migration of porcine trophectoderm cells through protooncogenic protein kinase 1 and extracellular-signal-regulated kinases 1/2 mitogen-activated protein kinase signal transduction cascades during early pregnancy.
Wooyoung Jeong, Jinyoung Kim, Fuller W Bazer, Gwonhwa Song.
Mol Cell Endocrinol, 2013 Sep 10; 381(1-2). PMID: 24012778
Alternative splicing and breast cancer.
Martin Dutertre, Stephan Vagner, Didier Auboeuf.
RNA Biol, 2010 Jul 14; 7(4). PMID: 20622514
A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic.
Wei Liu, Jie Li, +7 authors, Yongzhang Luo.
Cancer Sci, 2019 Jul 26; 110(9). PMID: 31343810    Free PMC article.
Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists.
Ping Yin, Wei Wang, +3 authors, Chenghai Zhao.
Cancer Sci, 2018 Aug 24; 109(11). PMID: 30137666    Free PMC article.
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Senkus, S Kyriakides, +5 authors, ESMO Guidelines Working Group.
Ann Oncol, 2013 Aug 24; 24 Suppl 6. PMID: 23970019
Highly Cited.
SpliceAid: a database of experimental RNA target motifs bound by splicing proteins in humans.
Francesco Piva, Matteo Giulietti, Linda Nocchi, Giovanni Principato.
Bioinformatics, 2009 Mar 06; 25(9). PMID: 19261717
Time-dependent ROC curves for censored survival data and a diagnostic marker.
P J Heagerty, T Lumley, M S Pepe.
Biometrics, 2000 Jul 06; 56(2). PMID: 10877287
Highly Cited.
Breast cancer in young women: an overview.
Zoi Anastasiadi, Georgios D Lianos, +2 authors, Michail Mitsis.
Updates Surg, 2017 Mar 06; 69(3). PMID: 28260181
Highly Cited. Review.
Identification of recurrent regulated alternative splicing events across human solid tumors.
Miri Danan-Gotthold, Regina Golan-Gerstl, +3 authors, Erez Y Levanon.
Nucleic Acids Res, 2015 Apr 25; 43(10). PMID: 25908786    Free PMC article.
Highly Cited.
Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.
Amy M Dworkin, Tim H-M Huang, Amanda Ewart Toland.
Semin Cancer Biol, 2009 May 12; 19(3). PMID: 19429480    Free PMC article.
The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.
Aurélie Bellanger, Caterina F Donini, +13 authors, Pascale A Cohen.
J Pathol, 2017 Feb 17; 242(1). PMID: 28207159
The Evolutionary Relationship between Alternative Splicing and Gene Duplication.
Luis P Iñiguez, Georgina Hernández.
Front Genet, 2017 Mar 07; 8. PMID: 28261262    Free PMC article.
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.
Yifan Wang, Andrea J Bernhardy, +36 authors, Neil Johnson.
Cancer Res, 2016 May 20; 76(9). PMID: 27197267    Free PMC article.
Highly Cited.
Dynamic integration of splicing within gene regulatory pathways.
Ulrich Braunschweig, Serge Gueroussov, +2 authors, Benjamin J Blencowe.
Cell, 2013 Mar 19; 152(6). PMID: 23498935    Free PMC article.
Highly Cited. Review.
Radiation-induced alternative transcription and splicing events and their applicability to practical biodosimetry.
Ellina Macaeva, Yvan Saeys, +6 authors, Roel Quintens.
Sci Rep, 2016 Jan 15; 6. PMID: 26763932    Free PMC article.
Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.
Hanna Kędzierska, Agnieszka Piekiełko-Witkowska.
Cancer Lett, 2017 Mar 21; 396. PMID: 28315432
Function of alternative splicing.
Olga Kelemen, Paolo Convertini, +4 authors, Stefan Stamm.
Gene, 2012 Aug 23; 514(1). PMID: 22909801    Free PMC article.
Highly Cited. Review.
MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.
Xiangjie Kong, Junfeng Zhang, +2 authors, Lin Fang.
Biochem Biophys Res Commun, 2018 May 11; 501(2). PMID: 29746865
Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness.
Burkhard Brandt, Jan-Hendrik Mikesch, +5 authors, Horst Bürger.
Biochem Biophys Res Commun, 2005 Feb 22; 329(1). PMID: 15721309
Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer.
Inès J Beumer, Marion Persoon, +9 authors, Annuska M Glas.
Biomark Insights, 2016 Dec 17; 11. PMID: 27980389    Free PMC article.
A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain.
A M Hossini, C C Geilen, +2 authors, J Eberle.
Oncogene, 2005 Nov 17; 25(15). PMID: 16288206
B cells and tertiary lymphoid structures promote immunotherapy response.
Beth A Helmink, Sangeetha M Reddy, +57 authors, Jennifer A Wargo.
Nature, 2020 Jan 17; 577(7791). PMID: 31942075
Highly Cited.
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.
Matthias Choschzick, Paula Lassen, +8 authors, Ronald Simon.
Mod Pathol, 2010 Feb 09; 23(4). PMID: 20139910
Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network.
Nature, 2012 Sep 25; 490(7418). PMID: 23000897    Free PMC article.
Highly Cited.
Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.
Yilin Xu, Xin D Gao, +11 authors, Chonghui Cheng.
Genes Dev, 2014 May 21; 28(11). PMID: 24840202    Free PMC article.
Highly Cited.
Tools and techniques--statistics: how many variables are allowed in the logistic and Cox regression models?
Ron van Domburg, Sanne Hoeks, +2 authors, Eric Boersma.
EuroIntervention, 2014 Apr 24; 9(12). PMID: 24755387
HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases.
Huizhi Sun, Tieju Liu, +7 authors, Yi Wang.
Genes Chromosomes Cancer, 2017 Apr 11; 56(8). PMID: 28393427
Breast cancer statistics, 2017, racial disparity in mortality by state.
Carol E DeSantis, Jiemin Ma, +2 authors, Ahmedin Jemal.
CA Cancer J Clin, 2017 Oct 04; 67(6). PMID: 28972651
Highly Cited.
Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures.
Zhe-Xu Cao, Guang-An Xiao, +5 authors, Ying-Hao Sun Prof.
J Cancer, 2019 Oct 22; 10(22). PMID: 31632503    Free PMC article.
TCGASpliceSeq a compendium of alternative mRNA splicing in cancer.
Michael Ryan, Wing Chung Wong, +5 authors, John Weinstein.
Nucleic Acids Res, 2015 Nov 26; 44(D1). PMID: 26602693    Free PMC article.
Highly Cited.
Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis.
Xueran Chen, Chenggang Zhao, +3 authors, Zhiyou Fang.
Front Oncol, 2019 Oct 15; 9. PMID: 31608231    Free PMC article.
Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption.
Stefan Meyer, Adam Stevens, +22 authors, Anthony D Whetton.
Cell Death Dis, 2017 Jun 16; 8(6). PMID: 28617445    Free PMC article.
Breast cancer management: opportunities and barriers to an individualized approach.
Edith A Perez.
Oncologist, 2011 Feb 10; 16 Suppl 1. PMID: 21278437
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.
M P Licciardello, M K Müllner, +13 authors, S Kubicek.
Oncogene, 2014 Sep 30; 34(29). PMID: 25263445
A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.
Youqin Xu, Kaiyuan Ji, +3 authors, Yang Xu.
Protein Cell, 2019 Feb 03; 10(8). PMID: 30710319    Free PMC article.
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Claudia Allemani, Tomohiro Matsuda, +21 authors, CONCORD Working Group.
Lancet, 2018 Feb 06; 391(10125). PMID: 29395269    Free PMC article.
Highly Cited.
The Immune Landscape of Cancer.
Vésteinn Thorsson, David L Gibbs, +55 authors, Ilya Shmulevich.
Immunity, 2018 Apr 10; 48(4). PMID: 29628290    Free PMC article.
Highly Cited.
Heterogeneity in breast cancer.
Kornelia Polyak.
J Clin Invest, 2011 Oct 04; 121(10). PMID: 21965334    Free PMC article.
Highly Cited.
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Kelly A Avery-Kiejda, Xu Dong Zhang, +4 authors, Peter Hersey.
Clin Cancer Res, 2008 Mar 04; 14(6). PMID: 18310316
Breast Cancer Treatment: A Review.
Adrienne G Waks, Eric P Winer.
JAMA, 2019 Jan 23; 321(3). PMID: 30667505
Highly Cited. Review.
The Functional Impact of Alternative Splicing in Cancer.
Héctor Climente-González, Eduard Porta-Pardo, Adam Godzik, Eduardo Eyras.
Cell Rep, 2017 Aug 31; 20(9). PMID: 28854369
Highly Cited.
GSVA: gene set variation analysis for microarray and RNA-seq data.
Sonja Hänzelmann, Robert Castelo, Justin Guinney.
BMC Bioinformatics, 2013 Jan 18; 14. PMID: 23323831    Free PMC article.
Highly Cited.
Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma.
Yongdi Zuo, Liang Zhang, Weihao Tang, Wanxin Tang.
J Cell Mol Med, 2019 Sep 07; 23(11). PMID: 31489763    Free PMC article.
Intron retention is a widespread mechanism of tumor-suppressor inactivation.
Hyunchul Jung, Donghoon Lee, +6 authors, Eunjung Lee.
Nat Genet, 2015 Oct 06; 47(11). PMID: 26437032
Highly Cited.
Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins.
María Jesús Ramírez-Expósito, José Manuel Martínez-Martos, +2 authors, María Pilar Carrera-González.
Breast Cancer Res Treat, 2020 Jun 09; 182(3). PMID: 32506336
Low C6orf141 Expression is Significantly Associated with a Poor Prognosis in Patients with Oral Cancer.
Cheng-Mei Yang, Hao-Sheng Chang, +6 authors, Kuo-Wang Tsai.
Sci Rep, 2019 Mar 16; 9(1). PMID: 30872783    Free PMC article.
ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.
Julie A Vendrell, Aurélie Thollet, +11 authors, Pascale A Cohen.
Cancer Res, 2012 May 18; 72(14). PMID: 22593193
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, George W Sledge.
N Engl J Med, 2019 Jun 04; 380(25). PMID: 31157962    Free PMC article.
Highly Cited.
Aberrant RNA Splicing in Cancer and Drug Resistance.
Bi-Dar Wang, Norman H Lee.
Cancers (Basel), 2018 Nov 23; 10(11). PMID: 30463359    Free PMC article.
Highly Cited. Review.
Building specificity with nonspecific RNA-binding proteins.
Ravinder Singh, Juan Valcárcel.
Nat Struct Mol Biol, 2005 Aug 04; 12(8). PMID: 16077728
Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer.
Min Yu, Weifeng Hong, +7 authors, Haosheng Jin.
Front Oncol, 2019 Sep 26; 9. PMID: 31552163    Free PMC article.
Exon-Mediated Activation of Transcription Starts.
Ana Fiszbein, Keegan S Krick, Bridget E Begg, Christopher B Burge.
Cell, 2019 Dec 04; 179(7). PMID: 31787377    Free PMC article.
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.
Paula Vainio, Santosh Gupta, +11 authors, Kristiina Iljin.
Am J Pathol, 2011 Feb 02; 178(2). PMID: 21281786    Free PMC article.
Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.
J K Taylor, Q Q Zhang, J R Wyatt, N M Dean.
Nat Biotechnol, 1999 Nov 05; 17(11). PMID: 10545916
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.
Mara Vinci, Anna Burford, +32 authors, Chris Jones.
Nat Med, 2018 Jul 04; 24(8). PMID: 29967352    Free PMC article.
Highly Cited.
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy.
Richard Buus, Ivana Sestak, +7 authors, Mitch Dowsett.
J Natl Cancer Inst, 2016 Jul 13; 108(11). PMID: 27400969    Free PMC article.
Highly Cited.